Originally posted by HESmith
View Post
Unconfigured Ad
Collapse
X
-
You can parse the reads this way (although your example is not ideal b/c A?GT is a match for both barcodes), or run the demultiplex.pl script (part of Illumina's CASAVA package) with the "--mismatches 1" flag.
Leave a comment:
-
Thank you, HESmith!
The barcodes are in the header so I am assuming I cannot use the utility in fastx_toolkit.
Does it make sense to list all possible barcodes that would be acceptable (i.e. those with one mismatch only, in any position) and then split the file according to this file?
For example:
Barcode1: ACGT
Acceptable1: ?CGT, A?GT, AC?T, ACG?
Barcode2:AGGT
Acceptable2: ?GGT, A?GT, AG?T, AGG?
Then the two output files will have the reads that match the acceptable barcode sets, while all other reads will be discarded?
Thanks!
Leave a comment:
-
The standard Illumina barcodes are designed to tolerate a single mismatch and still be assigned properly. The spurious barcodes you observe are typically associated with clusters that yield low-quality reads.
Leave a comment:
-
non-matching barcodes
Hi,
I have some RNASEQ data from Illumina 1.4+ pipeline.
The barcodes of a multiplex run are appended to the header line of the fastq file. I supposedly have two samples in there, so I am expecting two barcodes, however, I see also many other barcodes different from what I expected. The counts of these "spurious" barcodes is very low, so the majority of the sequences are associated to the expected barcodes.
When splitting the fastq file according to the barcode, how are the sequences with non-matching barcode handled? Do I allow 1 mismach? Do I keep exect matching criteria?
Thanks in advance.Tags: None
Latest Articles
Collapse
-
by SEQadmin2
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...-
Channel: Articles
10-14-2026, 09:55 AM -
-
by SEQadmin2
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...-
Channel: Articles
-
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 10-15-2026, 10:52 AM
|
0 responses
28 views
0 reactions
|
Last Post
by SEQadmin2
10-15-2026, 10:52 AM
|
||
|
Started by SEQadmin2, 10-14-2026, 05:39 AM
|
0 responses
36 views
0 reactions
|
Last Post
by SEQadmin2
10-14-2026, 05:39 AM
|
||
|
Started by SEQadmin2, 10-13-2026, 09:56 AM
|
0 responses
31 views
0 reactions
|
Last Post
by SEQadmin2
10-13-2026, 09:56 AM
|
||
|
Started by SEQadmin2, 10-09-2026, 11:14 AM
|
0 responses
29 views
0 reactions
|
Last Post
by SEQadmin2
10-09-2026, 11:14 AM
|
Leave a comment: